Bio

K. Randolph Peak is a Partner in Haynes Boone’s Dallas office and Co-Chair of the Healthcare and Life Sciences Practice Group. He also supports the firm’s Pharmaceuticals and Precision Medicine and Digital Health groups. Randy has served as a practical and strategic legal advisor in the healthcare, life sciences and technology sectors for decades, leveraging his extensive industry background and multidisciplinary experience as he counsels and represents clients ranging from multinational Fortune 100 enterprises to start-ups on a broad range of healthcare regulatory compliance and transactional matters. He routinely counsels clients on matters relating to fraud and abuse prohibitions, healthcare privacy, telemedicine, revenue cycle management, healthcare related licensing, outsourcing, strategic affiliations, and compliance with state corporate practice of medicine laws. Randy’s healthcare industry experience also includes serving as general counsel for a nationally recognized independent academic health system and deputy general counsel for one of the country’s largest healthcare supply chain, clinical consulting, and technology services organizations. In the technology sector, Randy’s in-house experience includes representing a global provider of software and technology where he negotiated numerous multi-million dollar commercial technology transactions worldwide. Randy’s clients include hospitals and health systems, physician groups, urgent care clinics, medical spas, health and wellness providers, clinical labs, AI and emerging healthcare technology companies, digital health vendors, healthcare data and analytics companies, healthcare supply chain distributors, medical device manufacturers, group purchasing organizations, health benefit management vendors, hospice and home health providers, retailers, senior and assisted living real estate developers, clinical research organizations, financial institutions, revenue cycle management service providers, private equity investors and portfolio companies, and joint ventures.